Douglas Stevenson, Jiing‐Huey Lin, Myron J. Tong, G. June Marshall – 1 November 1987 – A continuous adherent cell line was established from a hepatocellular carcinoma of an HBsAg‐positive Italian male. This cell line, designated Tong/HCC, has been grown in a hormone‐supplemented medium for more than 18 months. The cell line secretes HBsAg, α‐fetoprotein, albumin and α1‐antitrypsin. α‐Fetoprotein production is enhanced by the addition of hydrocortisone and appears to be glucocorticoid concentration‐dependent.

Edward L. Krawitt, Alan E. Kilby, Richard J. Albertini, Moses S. Schanfield, Bettejayne F. Chastenay, Phillip C. Harper, Ruth M. Mickey, Timothy L. McAuliffe – 1 November 1987 – The strategy of assigning a surrogate phenotype, defined as the presence of antinuclear and/or antismooth muscle antibodies to disease‐free first degree relatives of index cases was used to search for a postulated disease susceptibility gene in autoimmune chronic active hepatitis.

Jean‐Claude Homberg, Nisen Abuaf, Olivier Bernard, Shamsul Islam, Fernando Alvarez, Samir H. Khalil, Raoul Poupon, François Darnis, Victor‐Georges Lévy, Patrick Grippon, Pierre Opolon, Jacques Bernuau, Jean‐Pierre Benhamou, Daniel Alagille – 1 November 1987 – Sixty‐five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity.

Onni Niemelä, Felix Klajner, Hector Orrego, Eva Vidins, Laurence Blendis, Yedy Israel – 1 November 1987 – Acetaldehyde, the primary metabolite of ethanol, binds covalently to proteins forming condensation products which have been recently shown to be immunogenic.

Y. Katsuma, S. H. H. Swierenga, U. Khettry, N. Marceau, S. W. French – 1 November 1987 – Mouse and human extracted liver tissue were examined by indirect immunofluorescent staining and transmission electron microscopy in order to study the alteration of cytokeratin intermediate filaments associated with Mallory body formation. Frozen sections of griseofulvin‐fed mouse liver and human liver of primary biliary cirrhosis and primary sclerosing cholangitis were extracted by Triton X‐100 and nuclease.

Yasuhiro Mizoguchi, Hiroko Tsutsui, Keiji Miyajima, Yoshihide Sakagami, Shuichi Seki, Kenzo Kobayashi, Sukeo Yamamoto, Seiji Morisawa – 1 November 1987 – When a small amount of Gram‐negative lipopolysaccharide was intravenously injected into mice which had been injected with heat‐killed Propionibacterium acnes 7 days before, massive hepatic cell necrosis was induced and most of the mice died 24 hr later. However, when prostaglandin E1 was administered with lipopolysaccharide, remarkable improvements in the survival rate and in the histological changes of the liver were observed.

Santos Soberon, Mary P. Pauley, Richard Duplantier, Angelita Fan, Charles H. Halsted – 1 November 1987 – The etiology of malnutrition and the metabolic effect of aggressive nutritional support by enteral feeding were evaluated in patients with moderately severe alcoholic hepatitis.

Masao Yamada, William S. Blaner, Dianne Robert Soprano, Joseph L. Dixon, Hild M. Kjeldbye, Dewitt S. Goodman – 1 November 1987 – Hepatic stellate cells play a quantitatively important role in hepatic retinoid metabolism and storage in rats maintained under normal nutritional conditions. Studies were conducted to further explore the biochemical characteristics of hepatic stellate cells. Stellate cells were isolated in high purity and yield from the livers of normal rats.

Marsha Y. Morgan, Katherine E. Hawley – 1 November 1987 – Lactitol (β‐galactosido‐sorbitol) is a nonabsorbable disaccharide available as a powder which, in open comparison, is as effective as lactulose in the treatment of chronic hepatic encephalopathy, but is better tolerated. Twenty‐five cirrhotic patients experiencing 28 episodes of acute hepatic encephalopathy were randomized blindly to treatment with either lactitol (n = 15) or lactulose (n = 13).

Haim Matzkin – 1 November 1987 – Large‐scale epidemics of non‐B (HBsAg‐negative) hepatitis have occurred in the Israel Defense Forces prior to post‐ and preexposure immune serum globulin administration. Presently, hepatitis morbidity rates have stabilized around 1 to 2 per 1,000. Several years after vaccine initiation, a comparison of epidemiological features was made in order to redefine risk groups.